| NAME |
OZANIMOD 0.23MG X 4/0.46MG X 3 STARTER PACK,7 |
| VA GENERIC NAME |
OZANIMOD |
| DOSAGE FORM |
CAP,ORAL |
| FDA MED GUIDE |
Ozanimod_(Zeposia)_(Dec_2021).pdf |
| HAZARDOUS TO DISPOSE |
NO |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| NATIONAL FORMULARY NAME |
OZANIMOD CAP,ORAL |
| CREATE DEFAULT POSSIBLE DOSAGE |
NO |
| POSSIBLE DOSAGES TO CREATE |
No Possible Dosages |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2020-06-04 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
OZANIMOD 0.23MGX4/0.46MGX3 STARTER PAK,7 |
| VA PRODUCT IDENTIFIER |
O0415 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
PKT |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4039435 |
| EFFECTIVE DATE/TIME |
-
- 2020-06-04 00:00:00
- STATUS: ACTIVE
|
